Subscribe to Pulmonology

IM0271015 BMS-986278 for Progressive Pulm Fibrosis

Internal Medicine Pulmonology Lung Disease Adult Subjects

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

IM027068 BMS-986278 for Idiopathic Lung Fibrosis

Internal Medicine Pulmonology Lung Disease Adult Subjects

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

DAS181-3-01, DAS181, for Parainfluenza

Cancer Internal Medicine Infectious Disease Pulmonology COVID-19 Airway Disease Infectious Disease Pediatric Subjects Adult Subjects

This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.

It also contains a sub-study to enroll patients with severe COVID-19.

AR-DEX-22-01, Dexpramipexole for EOS asthma EXHALE

Internal Medicine Pulmonology Airway Disease Adult Subjects

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma with an eosinophilic phenotype and a history of asthma exacerbations.

MK5475-013

Internal Medicine Pulmonology Heart and Vascular Pulmonary Hypertension Airway Disease Heart Disease Lung Disease Adult Subjects Female Subjects Male Subjects

Researchers are looking for ways to treat pulmonary hypertension (PH) caused by chronic obstructive pulmonary disease (COPD). The goal of the study is to learn if people who take frespaciguat can walk farther in 6 minutes at Week 24 compared to people who take placebo.

Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Internal Medicine Pulmonology Airway Disease Lung Disease Adult Subjects

The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.